Epidemiology of cardiogenic shock and cardiac arrest complicating non-ST-segment elevation myocardial infarction:

Saraschandra Vallabhajosyula1,2,3, Jacob C Jentzer1,2, Abhiram Prasad1

  • 1Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

ESC Heart Failure
|April 10, 2021
PubMed

Insights

The combination of cardiogenic shock (CS) and cardiac arrest (CA) significantly increases mortality and organ failure in non-ST-segment elevation myocardial infarction (NSTEMI) patients. This dual complication leads to worse outcomes than either condition alone.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Health Services Research

Background:

  • Non-ST-segment elevation myocardial infarction (NSTEMI) is a common presentation of acute coronary syndrome.
  • Cardiogenic shock (CS) and cardiac arrest (CA) are severe complications that can arise during NSTEMI.
  • The combined impact of CS and CA on NSTEMI outcomes is not fully elucidated.

Purpose of the Study:

  • To evaluate the impact of the combination of cardiogenic shock (CS) and cardiac arrest (CA) in patients with non-ST-segment elevation myocardial infarction (NSTEMI).
  • To compare outcomes between NSTEMI patients with CS only, CA only, both CS and CA, and neither complication.

Main Methods:

  • Analysis of adult NSTEMI admissions from the National Inpatient Sample database (2000-2017).
  • Stratification of patients based on the presence of CS and/or CA.
  • Comparison of in-hospital mortality, early coronary angiography rates, hospitalization costs, and length of stay.

Main Results:

  • NSTEMI admissions with both CS and CA showed significantly higher rates of multiorgan failure compared to CS alone or CA alone.
  • The CS + CA cohort experienced substantially higher in-hospital mortality (aOR 4.12) compared to CS alone, CA alone, or no CS/CA.
  • NSTEMI patients with CS (alone or with CA) had increased hospitalization costs and longer hospital stays.

Conclusions:

  • The combination of CS and CA in NSTEMI admissions is associated with a significantly higher risk of acute non-cardiac organ failure.
  • NSTEMI patients experiencing both CS and CA have markedly worse in-hospital mortality rates compared to those with either complication individually.
  • The presence of CS, particularly when combined with CA, represents a critical factor driving adverse outcomes, increased costs, and prolonged hospitalizations in NSTEMI.
Abstract

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
96
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
247
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
74
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
181
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
111
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
204